PG2
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for PG2, covering 2025-06-04 to 2025-06-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients [Phase 2]